Literature DB >> 4329122

Hypersensitivity reactions to ampicillin in cytomegalovirus mononucleosis.

E Klemola.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4329122     DOI: 10.3109/inf.1970.2.issue-1.05

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


× No keyword cloud information.
  10 in total

1.  Editorial: Ampicillin rashes.

Authors: 
Journal:  Br Med J       Date:  1975-06-28

2.  Infectious mononucleosis and mononucleosis syndromes.

Authors:  M Fiala; D C Heiner; J A Turner; B Rosenbloom; L B Guze
Journal:  West J Med       Date:  1977-06

3.  IgM and IgG antibody levels to ampicillin in patients with infectious mononucleosis.

Authors:  H McKenzie; D Parratt; R G White
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

4.  Double-blind clinical trials of oral cyclacillin and ampicillin.

Authors:  J A Gold; C P Hegarty; M W Deitch; B R Walker
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

Review 5.  Penicillin allergy.

Authors:  J E Erffmeyer
Journal:  Clin Rev Allergy       Date:  1986-05

6.  Allergic manifestations of human immunodeficiency virus (HIV) infection.

Authors:  A Carr; D A Cooper; R Penny
Journal:  J Clin Immunol       Date:  1991-03       Impact factor: 8.317

7.  Trimethoprim-sulfamethoxazole desensitization in AIDS.

Authors:  G Papakonstantinou; H Füessl; R Hehlmann
Journal:  Klin Wochenschr       Date:  1988-04-15

8.  Prospective study of ampicillin rash. Report of a collaborative study group.

Authors: 
Journal:  Br Med J       Date:  1973-01-06

9.  Cytomegalovirus: Clinical virological correlations in renal transplant recipients.

Authors:  R L Simmons; C Lopez; H Balfour; J Kalis; L C Rattazzi; J S Najarian
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

Review 10.  The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.

Authors:  Carina M Woodruff; Nina Botto
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-03       Impact factor: 10.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.